Leading Financial Service Provider in India | Canara Bank Securities Ltd

(27/05/2026 18:30)

Bal Pharma - Board Meeting Outcome for Outcome Of The Board Meeting

Board of Directors of the Company has met today and transacted following business,\r\n1. Approved audited financial results of the Company for the quarter and financial year ended 31.03.2026.\r\n2.Recommend dividend of Rs1.20 per equity share of Rs.10 each i.e 12%\r\n3.Appointed Cost Auditors and Internal auditors for the financial year 2026.27.\r\n4. Approved grant of 5,00,000 stock options to the employees of the company under \Bal Pharma Ltd-Employee Stock Option Plan-2025\\r\n5.Approved preferential issue of 10,00,000 warrants to the promoters.\r\n6. Take shareholders approval for preferential issue through postal ballot.\r\n7.Approved appointment of Mr.Shreepada M.L (M # A66681) as Company Secretary and compliance officer of the company.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.

KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Markets

News Details